Phyla Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 14

Phyla General Information

Description

Developer of probiotic skincare products designed to treat acne. The company's line of products utilizes microbiome technology to build a minimalist acne system that delivers health benefits with minimum skin damage, enabling customers to have access to an effective means of treating acne without harming the skin.

Contact Information

Website
www.phylabiotics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1250 Petaluma Boulevard North
  • Petaluma, CA 94952
  • United States
+1 (707) 000-0000
Primary Industry
Personal Products
Other Industries
Biotechnology
Vertical(s)
Beauty, E-Commerce, Life Sciences
Corporate Office
  • 1250 Petaluma Boulevard North
  • Petaluma, CA 94952
  • United States
+1 (707) 000-0000

Phyla Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Phyla Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private 00.00 Completed Generating Revenue
6. Later Stage VC (Series A) 26-Jun-2024 00.000 00.00 000.00 Completed Generating Revenue
5. Later Stage VC 07-Dec-2023 00.000 Completed Generating Revenue
4. Accelerator/Incubator 12-Jan-2021 00.000 Completed Generating Revenue
3. Seed Round 04-Jun-2019 00.000 00.000 000 Completed Generating Revenue
2. Grant 05-Sep-2015 $165K Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Phyla’s complete valuation and funding history, request access »

Phyla Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-2 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A-1 0,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series A 2,556,028 $0.001000 8% $1.96 $1.96 1x $1.96 9.28%
Seed 1,805,773 $0.001000 8% $0.87 $0.87 1x $0.87 21.86%
To view Phyla’s complete cap table history, request access »

Phyla Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of probiotic skincare products designed to treat acne. The company's line of products utilizes microbiome tech
Personal Products
Petaluma, CA
10 As of 2022
00.00
000000 - 000 00.00

000000

e eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
00000000 00000000
San Diego, CA
0 As of 0000
00.000
0000000000 00.000

00 000

cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non pr
00000000 00000000
Westfield, NJ
000 As of 0000
00000
00.00 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Phyla Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dermala Venture Capital-Backed San Diego, CA 0 00.000 0000000000 00.000
It Cosmetics Formerly PE-Backed Westfield, NJ 000 00000 000000&0 00000
Pai Skincare Venture Capital-Backed London, United Kingdom 00 000.00 00000000000 000.00
Kiehl's Since 1851 Corporate Backed or Acquired New York, NY 000 000000&0
Oskia Corporation London, United Kingdom 00
You’re viewing 5 of 5 competitors. Get the full list »

Phyla Patents

  • 8

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 6

    Pending

  • 000

    Expiring in next 12 mo

Phyla Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3612200-A1 Compositions comprising propionibacterium acnes bacteriophages for treating acne Pending 21-Apr-2017 000000000
US-20210338569-A1 Compositions comprising propionibacterium acnes bacteriophages for treating acne Pending 21-Apr-2017 000000000
EP-3612200-A4 Compositions comprising propionibacterium acnes bacteriophages for treating acne Pending 21-Apr-2017 00000000 0
AU-2018255972-A1 Compositions comprising propionibacterium acnes bacteriophages for treating acne Pending 21-Apr-2017 000000000
CA-3060415-A1 Compositions comprising propionibacterium acnes bacteriophages for treating acne Pending 21-Apr-2017 A61P17/10
To view Phyla’s complete patent history, request access »

Phyla Executive Team (4)

Name Title Board Seat
Yug Varma Ph.D Co-Founder, Chief Technology Officer, Co-Chief Executive Officer & Board Member
Neil Giugno Co-Chief Executive Officer & Board Member
Maria Cho Co-Founder, Chief Operating Officer & Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

Phyla Board Members (4)

Name Representing Role Since
Jun Li CRCM Ventures Board Member 000 0000
Kevin Law Self Board Member 000 0000
Maria Cho Self Co-Founder, Chief Operating Officer & Board Member 000 0000
Neil Giugno Phyla Co-Chief Executive Officer & Board Member 000 0000
To view Phyla’s complete board members history, request access »

Phyla Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phyla Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Brandon Shainfeld Angel (individual) Minority 000 0000 000000 0
Maximum Effort Productions Corporation Minority 000 0000 000000 0
N Plus One Ventures Venture Capital Minority 000 0000 000000 0
Willow Growth Partners Venture Capital Minority 000 0000 000000 0
QB3 Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

Phyla FAQs

  • When was Phyla founded?

    Phyla was founded in 2014.

  • Who is the founder of Phyla?

    Yug Varma Ph.D, Nancy Prooyen Ph.D, and Maria Cho are the founders of Phyla.

  • Who is the CEO of Phyla?

    Yug Varma Ph.D and Neil Giugno are the CEOs of Phyla.

  • Where is Phyla headquartered?

    Phyla is headquartered in Petaluma, CA.

  • What is the size of Phyla?

    Phyla has 10 total employees.

  • What industry is Phyla in?

    Phyla’s primary industry is Personal Products.

  • Is Phyla a private or public company?

    Phyla is a Private company.

  • What is Phyla’s current revenue?

    The current revenue for Phyla is 00000.

  • How much funding has Phyla raised over time?

    Phyla has raised $9.2M.

  • Who are Phyla’s investors?

    Brandon Shainfeld, Maximum Effort Productions, N Plus One Ventures, Willow Growth Partners, and QB3 are 5 of 14 investors who have invested in Phyla.

  • Who are Phyla’s competitors?

    Dermala, It Cosmetics, Pai Skincare, Kiehl's Since 1851, and Oskia are competitors of Phyla.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »